Kidney transplantation is safe and effective for treating children with ANCA-associated vasculitis (AAV) who develop serious kidney problems as…
Ana Pena, PhD
Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she focused her research on molecular biology, epigenetics and infectious diseases.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Pena, PhD
Mutant Blood Cells Relatively Common in AAV Patients and Carry Risks and Benefits, Study Suggests
The development of a population of mutated blood cells — a phenomenon called clonal hematopoiesis of indeterminate potential — is…
More people with ANCA-associated vasculitis (AAV), including those with kidney involvement, also have connective tissue diseases (CTD) than is…
Healthy individuals also produce a type of self-reactive antibodies — termed IgM ANCA — present in people with ANCA-associated…
The neutrophils of patients with granulomatosis with polyangiitis (GPA) have altered levels of proteins involved in neutrophil clearance, which…
Eye problems are a common symptom of granulomatosis with polyangiitis, of which…
Treatment with a common antibiotic reduces the risk of life-threatening infections in ANCA-associated vasculitis patients being given Rituxan (rituximab)…
Ultrasounds May Help Predict Artery Damage, Risk of Heart Problems in GPA Patients, Study Shows
A noninvasive and simple ultrasound test might be a new tool to help predict artery damage and increased…
Classifying the specificity of ANCA autoantibodies may complement the currently used clinical classification system when predicting the course of disease and…
Patients with ANCA-associated glomerulonephritis receiving immunosuppressive therapy are not more likely to develop cancer than the general population, a…